Unintended HIV-1 Infection During Analytical Therapy Interruption

J Infect Dis. 2020 Apr 27;221(10):1740-1742. doi: 10.1093/infdis/jiz611.

Authors

Ainoa Ugarte¹, Yolanda Romero¹, Amparo Tricas¹, Concepcion Casado², Cecilio Lopez-Galindez², Felipe Garcia^{1

3}, Lorna Leal^{1

3}

Affiliations

¹ Infectious Diseases-HIV Unit, Hospital Clínic Barcelona, University of Barcelona, Spain.
² Molecular Virology Unit, Reference Laboratory and Retroviruses Research, Microbiology National Center, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
³ AIDS Research Group-HIVACAT (HIV Vaccine development program in Catalonia), Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.

PMID: 31742347
DOI: 10.1093/infdis/jiz611

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

AIDS Vaccines / immunology
Adult
Anti-HIV Agents / administration & dosage*
Anti-HIV Agents / therapeutic use*
Drug Contamination
HIV Infections / drug therapy*
HIV Infections / prevention & control
HIV Infections / transmission*
HIV-1 / genetics*
Humans
Male
Phylogeny
Sexual Partners

Substances

AIDS Vaccines
Anti-HIV Agents